reports
- MarketLine Department
Salix Pharmaceuticals, Ltd. - Mergers & Acquisitions (M&A), Partnershi...
Summary Marketline's Salix Pharmaceuticals, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Salix Pharmaceuticals, Ltd. since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakd...
1 director sold
A director at Cumberland Pharmaceuticals Inc sold 11,570 shares at 5.295USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Co...
NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) concerning possible breaches of fiduciary duty. To obtain additional information, go to: http://zlk.9nl.com/cumberland-pharmaceuticals-cpix or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you. Levi & Korsinsky is a national firm with offices in New York,...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.